BLAUSTEIN MARC (Chief Operating Officer) received a stock award from FINCH THERAPEUTICS GROUP, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2022ACC: 0000899243-22-022623
Officer· Chief Operating Officer
Since Sep 2021
+35K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35K
Price / share
—
Trade value
—
% of position
2800.0%
6/13/2022
1.25K→36.25K
Total
Net shares
+35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2022 | A · Award | +35K | — | — | 2800.0% | 1.25K | 36.25K |
| Total | +35K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported